BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 16984392)

  • 1. Development of autologous cytotoxic CD4+ T clones in a human model of B-cell non-Hodgkin follicular lymphoma.
    Mi JQ; Manches O; Wang J; Perron P; Weisbuch S; Marche PN; Renversez JC; Bensa JC; Sotto JJ; Cahn JY; Leroux D; Bonnefoix T
    Br J Haematol; 2006 Nov; 135(3):324-35. PubMed ID: 16984392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones.
    van Binnendijk RS; Poelen MC; de Vries P; Voorma HO; Osterhaus AD; Uytdehaag FG
    J Immunol; 1989 Apr; 142(8):2847-54. PubMed ID: 2467943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional heterogeneity among herpes simplex virus-specific human CD4+ T cells.
    Yasukawa M; Inatsuki A; Horiuchi T; Kobayashi Y
    J Immunol; 1991 Feb; 146(4):1341-7. PubMed ID: 1671404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones.
    Koide J; Engleman EG
    J Immunol; 1990 Jan; 144(1):32-40. PubMed ID: 1967266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of autologous CD4- and CD8-mediated T-cell responses against acute lymphocytic leukemia cell line using apoptotic tumor cell-loaded dendritic cells.
    Hatakeyama N; Tamura Y; Sahara H; Suzuki N; Suzuki K; Hori T; Mizue N; Torigoe T; Tsutsumi H; Sato N
    Exp Hematol; 2006 Feb; 34(2):197-207. PubMed ID: 16459188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma.
    Cooper LJ; Ausubel L; Gutierrez M; Stephan S; Shakeley R; Olivares S; Serrano LM; Burton L; Jensen MC; Forman SJ; DiGiusto DL
    Cytotherapy; 2006; 8(2):105-17. PubMed ID: 16698684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.
    Sun Q; Burton RL; Pollok KE; Emanuel DJ; Lucas KG
    Cell Immunol; 1999 Aug; 195(2):81-8. PubMed ID: 10448007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in direct cytotoxic function of L3T4 T cells. TH1 clones express higher cytotoxic activity to antigen-presenting cells than TH2 clones.
    Chang JC; Zhang L; Edgerton TL; Kaplan AM
    J Immunol; 1990 Jul; 145(2):409-16. PubMed ID: 1973181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors.
    Merlo A; Turrini R; Bobisse S; Zamarchi R; Alaggio R; Dolcetti R; Mautner J; Zanovello P; Amadori A; Rosato A
    J Immunol; 2010 May; 184(10):5895-902. PubMed ID: 20385879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of Epstein-Barr virus-specific human CD4+ T lymphocyte clones.
    Honda S; Takasaki T; Okuno K; Yasutomi M; Kurane I
    Acta Virol; 1998 Nov; 42(5):307-13. PubMed ID: 10358731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.
    Roszkowski JJ; Lyons GE; Kast WM; Yee C; Van Besien K; Nishimura MI
    Cancer Res; 2005 Feb; 65(4):1570-6. PubMed ID: 15735047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
    Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity.
    van der Veken LT; Hoogeboom M; de Paus RA; Willemze R; Falkenburg JH; Heemskerk MH
    Gene Ther; 2005 Dec; 12(23):1686-95. PubMed ID: 16034453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones.
    Umetsu DT; Esserman L; Donlon TA; DeKruyff RH; Levy R
    J Immunol; 1990 Apr; 144(7):2550-7. PubMed ID: 1969451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
    Kleindienst P; Brocker T
    Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The characteristics of anti-B-cell malignance cytotoxic T lymphocytic clones induced by lymphoma relative peptides].
    Guo XL; Zhu P; Zhu X; Liu J; Ou Y; Du JW
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1476-80. PubMed ID: 16061026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.
    Merlo A; Saverino D; Tenca C; Grossi CE; Bruno S; Ciccone E
    Infect Immun; 2001 Oct; 69(10):6022-9. PubMed ID: 11553539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificities and functions of CD4+ HLA class II-restricted T cell clones against a human sarcoma: evidence for several recognized antigens.
    Heike M; Schlaak J; Schulze-Bergkamen H; Heyl S; Herr W; Schmitt U; Schneider PM; Meyer zum Büschenfelde KH
    J Immunol; 1996 Mar; 156(6):2205-13. PubMed ID: 8690910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
    Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
    J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebuilding human leukocyte antigen class II-restricted minor histocompatibility antigen specificity in recall antigen-specific T cells by adoptive T cell receptor transfer: implications for adoptive immunotherapy.
    Spaapen R; van den Oudenalder K; Ivanov R; Bloem A; Lokhorst H; Mutis T
    Clin Cancer Res; 2007 Jul; 13(13):4009-15. PubMed ID: 17606735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.